JP2024532412A5 - - Google Patents

Info

Publication number
JP2024532412A5
JP2024532412A5 JP2024513322A JP2024513322A JP2024532412A5 JP 2024532412 A5 JP2024532412 A5 JP 2024532412A5 JP 2024513322 A JP2024513322 A JP 2024513322A JP 2024513322 A JP2024513322 A JP 2024513322A JP 2024532412 A5 JP2024532412 A5 JP 2024532412A5
Authority
JP
Japan
Prior art keywords
seq
pharmaceutical composition
asthma
peptide
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024513322A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024532412A (ja
Filing date
Publication date
Priority claimed from US17/409,642 external-priority patent/US20210379141A1/en
Application filed filed Critical
Priority claimed from PCT/US2022/075356 external-priority patent/WO2023028491A1/en
Publication of JP2024532412A publication Critical patent/JP2024532412A/ja
Publication of JP2024532412A5 publication Critical patent/JP2024532412A5/ja
Pending legal-status Critical Current

Links

JP2024513322A 2021-08-23 2022-08-23 肺疾患を処置及び予防するための組成物及び方法 Pending JP2024532412A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17/409,642 2021-08-23
US17/409,642 US20210379141A1 (en) 2016-04-11 2021-08-23 Compositions and methods for treating and preventing lung disease
PCT/US2022/075356 WO2023028491A1 (en) 2021-08-23 2022-08-23 Compositions and methods for treating and preventing lung disease

Publications (2)

Publication Number Publication Date
JP2024532412A JP2024532412A (ja) 2024-09-05
JP2024532412A5 true JP2024532412A5 (https=) 2025-08-29

Family

ID=85278728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513322A Pending JP2024532412A (ja) 2021-08-23 2022-08-23 肺疾患を処置及び予防するための組成物及び方法

Country Status (6)

Country Link
EP (1) EP4392052A4 (https=)
JP (1) JP2024532412A (https=)
KR (1) KR20240052799A (https=)
CN (1) CN118076372A (https=)
AU (1) AU2022332283A1 (https=)
CA (1) CA3175945A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017180546A1 (en) * 2016-04-11 2017-10-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing lung disease
EP4132470A4 (en) * 2020-04-08 2023-11-08 Arizona Board of Regents on behalf of the University of Arizona COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF LUNG DISEASES

Similar Documents

Publication Publication Date Title
ES2780127T3 (es) Formulación superfina de formoterol
US20080167230A1 (en) Methods and compositions for treating or preventing lesions of the respiratory epithelium
JP2005532988A5 (https=)
US20090227511A1 (en) Methods and compositions for treating lesions of the respiratory epithelium
JP2002538110A (ja) 喘息用のフォルモテロールおよびモメタゾンフロエートの組合せ
US20040198708A1 (en) Formulations of mometasone and a bronchodilator for pulmonary administration
JP2002537249A (ja) 喘息のためのホルモテロールおよびプロピオン酸フルチカゾンの組み合わせ
JP2002536408A (ja) フォルモテロールとチオトロピウム塩の組合わせ
JP2012505262A (ja) Copd及びその他の肺疾患の治療方法
AU2020226339B2 (en) Methods of treatment of respiratory disorders
JP2014525471A (ja) 咳および咳発作の治療
TWI905086B (zh) 包含雷芬那新(revefenacin)之醫藥組合物用於治療慢性阻塞性肺疾病之用途及選擇治療用之吸入遞送裝置之方法
AU2005316687B2 (en) Compositions and methods for pulmonary conditions
JP2024532412A5 (https=)
US6592848B1 (en) Mixtures of oxygen and helium for the treatment of respiratory insufficiency
WO2020032910A1 (ru) Фармацевтическая композиция, лекарственное средство и способ лечения бронхолегочных обструктивных заболеваний
US20060025392A1 (en) Combination medicament
JP6021952B2 (ja) 慢性閉塞性肺疾患の治療法
US20060292085A1 (en) Medicaments
JP2024546201A5 (https=)
Pauwels et al. Influence of an extension tube on the bronchodilator efficacy of terbutaline delivered from a metered dose inhaler
CN118076372A (zh) 治疗和预防肺病的组合物和方法
WO2024077042A2 (en) Il-1 receptor antagonist treatment for neutrophilic lung disease
WO2021211006A1 (en) Inhaled hexapeptide for treating interleukin-6 related respiratory diseases
CN110664819A (zh) 供吸入的齐墩果酸制剂及其制备方法与医药用途